Factor | No. of HBsAg+ / No. of Tested | % | Univariate | Multivariable†| ||
---|---|---|---|---|---|---|
Crude OR (95% CI) | p | Adjusted OR (95% CI) | p | |||
Population | 4011 | Â | Â | Â | Â | Â |
 Heterosexual | 39/851 | 4.6 | Reference |  | Reference |  |
 MSM | 182/2941 | 6.2 | 1.37 (0.96 to 1.96) | 0.079 | 1.64 (1.13 to 2.40) | 0.010 |
 TGW | 20/215 | 9.3 | 2.14 (1.22 to 3.74) | 0.008 | 2.87 (1.60 to 5.17) | <  0.001 |
 TGM | 1/4 | 25.0 | 6.94 (0.71 to 68.3) | 0.097 | 5.77 (0.57 to 58.7) | 0.138 |
Birth year | 4011 | Â | Â | Â | Â | Â |
  <  1992 | 176/2167 | 8.1 | 2.38 (1.78 to 3.18) | <  0.001 | 2.32 (1.69 to 3.16) | <  0.001 |
  ≥ 1992 | 66/1844 | 3.6 | Reference |  | Reference |  |
Monthly income (baht) | 1337 | Â | Â | Â | Â | Â |
  ≤ 10,000 | 7/256 | 2.7 | Reference |  |  |  |
  > 10,000 | 71/1081 | 6.6 | 2.50 (1.14 to 5.50) | 0.023 |  |  |
Residential location | 2019 | Â | Â | Â | Â | Â |
 Bangkok | 75/1381 | 5.4 | Reference |  |  |  |
 Outside Bangkok | 41/638 | 6.4 | 1.20 (0.81 to 1.77) | 0.372 |  |  |
Educational level | 2320 | Â | Â | Â | Â | Â |
 College or above | 89/1526 | 5.8 | Reference |  |  |  |
 High school or below | 49/794 | 6.2 | 1.06 (0.74 to 1.52) | 0.743 |  |  |
Anti-HCV | 3990 | Â | Â | Â | Â | Â |
 Negative | 209/3826 | 5.5 | Reference |  |  |  |
 Positive | 12/164 | 7.3 | 1.37 (0.75 to 2.50) | 0.311 |  |  |
CD4 count (cells/mm3) | 4004 | Â | Â | Â | Â | Â |
  < 200 | 86/1038 | 8.3 | 1.65 (1.25 to 2.17) | <  0.001 | 1.38 (1.03 to 1.86) | 0.031 |
  ≥ 200 | 154/2966 | 5.2 | Reference |  | Reference |  |
ALT (U/L) | 3976 | Â | Â | Â | Â | Â |
  < 62.5 | 177/3623 | 4.9 | Reference |  | Reference |  |
  ≥ 62.5 | 42/353 | 11.9 | 2.63 (1.84 to 3.75) | <  0.001 | 2.39 (1.66 to 3.43) | <  0.001 |
CrCl (ml/min) | 3923 | Â | Â | Â | Â | Â |
  < 60 | 0/29 | 0.0 | – |  |  |  |
  ≥ 60 | 213/3894 | 5.5 | – | – |  |  |
Syphilis | 3972 | Â | Â | Â | Â | Â |
 Negative | 171/3205 | 5.3 | Reference |  |  |  |
 Positive | 54/767 | 7.0 | 1.34 (0.98 to 1.84) | 0.067 |  |  |